Extended Data Fig. 3: Minimal residual disease concordance of candidate variants. | Nature Cancer

Extended Data Fig. 3: Minimal residual disease concordance of candidate variants.

From: Whole-exome tumor-agnostic ctDNA analysis enhances minimal residual disease detection and reveals relapse mechanisms in localized colon cancer

Extended Data Fig. 3

Median concordance of candidate variants when selecting the 16 somatic mutations with the highest VAF for MRD monitoring in primary tumor and plasma baseline samples within the discovery cohort (left, n = 12 patients) and the validation cohort (right, n = 14 patients). Two-sided Wilcoxon test; p-value = 0.047.

Source data

Back to article page